September 30, 2016 3:49 PM ET

Pharmaceuticals

Company Overview of AstraZeneca PLC

Executive Profile

Donald Bruce Burlington M.D.

Non-Executive Director, Chairman of Science Committee, Member of Audit Committee and Member of Nomination & Governance Committee, AstraZeneca PLC
AgeTotal Calculated CompensationThis person is connected to 4 Board Members in 4 different organizations across 5 different industries.

See Board Relationships
67114,000 GBP

Background

Dr. Donald Bruce Burlington, M.D. serves as a Consultant in pharmaceutical development and regulatory affairs. Dr. Burlington serves as a Senior Consultant of Regulatory Affairs of BioSurface Engineering Technologies, Inc. and focuses on drug and combination product development, regulatory strategy and advisory committee preparation in the U.S. and the EU. Dr. Burlington served as an Executive Vice President of Business Practices and Compliance of Wyeth Pharmaceuticals ...

Corporate Headquarters

2 Kingdom Street
London, Greater London W2 6BD

United Kingdom

Phone: 44 20 7604 8000
Fax: --

Board Members Memberships

2008-Present
Independent Director, Chairman of Human Resources & Compensation Committee and Member of Audit Committee
2010-Present
Non-Executive Director, Chairman of Science Committee, Member of Audit Committee and Member of Nomination & Governance Committee

Education

BA
Louisiana Tech University
MD 1976
Louisiana State University

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

Total Annual Cash Compensation114,000 GBP
Total Calculated Compensation114,000 GBP
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Brenton L. Saunders J.D.Chief Executive Officer, President and Director
Allergan plc
$1.0M
Werner Baumann Chairman of the Board of Management and Chief Executive Officer
Bayer AG
$1.8M
Lars Rebien Sørensen Chief Executive Officer, President and Chairman of Operations Committee
Novo Nordisk A/S
$21.2M
Kurt W. Bock Chairman of the Board of Executive Directors
BASF SE
$3.9M
Olivier Brandicourt M.D.Chief Executive Officer, Director and Member of Strategy Committee
Sanofi
$2.4M
Compensation as of Fiscal Year 2015.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact AstraZeneca PLC, please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.